Certara

Certara Simcyp Group Awarded Two New Grants from US FDA

Programmes focus on use of physiologically-based pharmacokinetic (PBPK) modelling for demonstrating virtual bioequivalence and predicting drug absorption of topical formulations 29 August 2023 — New Jersey, US — Certara, a global leader in biosimulation, today announced that the Simcyp group has been awarded two new grants from the US Food and Drug Administration (FDA) to expand its predictive…
100 Overlook Center, Suite 101, Princeton, NJ 08540

+1 415-CER-TARA (237-8272)